Longevity Health Holdings revenue was $50.32k for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $17.5k, down 14.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, XAGE annual revenue was $50.3k, with Infinity% growth year-over-year.
XAGE revenue history
Current Revenue
$50.3k
Current Earnings
-$10.4M
Current Profit Margin
-20,605.5%
Be the first to know when XAGE announces revenue.
XAGE Revenue History By Year
XAGE Yearly Revenue
XAGE Revenue
XAGE Change
XAGE Revenue Growth
2024-12-31
$50.32k
N/A
N/A
2023-12-31
$0.00
N/A
N/A
2022-12-31
$0.00
N/A
N/A
2021-12-31
$0.00
N/A
N/A
1 of 1
Longevity Health Holdings Revenue FAQ
What was XAGE's revenue last quarter?
Longevity Health Holdings (NASDAQ: XAGE) reported Q4 2024 revenue of $17.48 thousand up Infinity% year over year. In the same quarter last year, Longevity Health Holdings's revenue was $0.00.
What was Longevity Health Holdings's revenue in 2024?
Longevity Health Holdings's annual revenue for the twelve months ending Dec 31, 2024 was $50.32 thousand, a Infinity% increase year over year.
How much does Longevity Health Holdings make in a day?
Based on Longevity Health Holdings annual revenue for the past three years, XAGE makes an average of $45.95 per day.
What was Longevity Health Holdings's annual revenue growth in the past year?
As of Q2 2025, Longevity Health Holdings's revenue has grown null year over year. Longevity Health Holdings's revenue in the past year totaled $50.32 thousand.
How much does Longevity Health Holdings make in a year?
Longevity Health Holdings's revenue by year for the past three years is:
Longevity Health Holdings's revenue for the twelve months ending Dec 31, 2024 was $50.32 thousand, a Infinity% increase year over year.
Longevity Health Holdings's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
Longevity Health Holdings's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.